(Alliance News) - Belluscura PLC on Tuesday withdrew its previous financial guidance for 2025, citing to the US imposition of tariffs on imports.

Belluscura, the AIM-listed portable oxygen therapy business, today withdrew financial guidance amid uncertainty over the ...

The medical equipment developer said it is assessing the potential financial implications, particularly from the 54% tariff ...

In a viral TikTok post shared March 17, mother Melissa Sotomayor claimed a United Airlines flight crew harassed her and her ...

The hospital is partnering with the Nebraska Recycling Council, Assistive Technology Partnership and Keep Omaha Beautiful for ...